ADCC Mediated B-Cell dEpletion and BAFF-R Blockade

Clinical trial NCT03217422 · COMPLETED

Trial details

NCT number: NCT03217422
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Autoimmune Hepatitis

Start date: 2018-02-15
Primary completion: 2023-12-28
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.